Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionTwo Sigma Investments, Lp
ManagerJohn Overdeck, David Siegel
Latest Disclosed Ownership3,060,570 shares
Latest Disclosed Value $ 403,199,492
Two Sigma Investments, Lp ownership in NBIX / Neurocrine Biosciences, Inc.

On May 15, 2026 - Two Sigma Investments, Lp filed a 13F-HR form disclosing ownership of 3,060,570 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $403,199,492 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 984,811 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 210.78% during the quarter.

Two Sigma Investments, Lp has a history of taking positions in derivatives of the underlying security (NBIX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:NBIX / Neurocrine Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,060,570 2,075,759 210.78 403,199 188.67 0.3253
2026-02-17 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 984,811 637,246 183.35 139,676 186.27 0.1970
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 347,565 347,565 48,791 0.0726
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -10,202 -100.00 0 -100.00
2025-05-15 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 10,202 -16,569 -61.89 1,128 -69.13 0.0024
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 26,771 -63,257 -70.26 3,654 -64.77 0.0080
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 90,028 -45,254 -33.45 10,373 -44.30 0.0227
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 135,282 -22,498 -14.26 18,624 -14.42 0.0424
2024-05-15 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 157,780 -67,127 -29.85 21,761 -26.56 0.0511
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 224,907 174,499 346.17 29,634 422.63 0.0681
2023-11-14 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 50,408 -187,378 -78.80 5,671 -74.71 0.0153
2023-08-14 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 237,786 -132,292 -35.75 22,423 -40.14 0.0562
2023-05-15 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 370,078 -200,943 -35.19 37,459 -45.08 0.1071
2023-02-14 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 571,021 202,201 54.82 68,203 74.11 0.2141
2022-11-14 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 368,820 345,155 1,458.50 39,172 1,597.96 0.1331
2022-08-15 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 23,665 -342,898 -93.54 2,307 -93.29 0.0076
2022-05-16 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 366,563 199,448 119.35 34,365 141.45 0.1014
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 167,115 167,115 14,233 0.0304
2020-11-16 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -138,992 -100.00 0 -100.00
2020-08-14 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 138,992 -172,836 -55.43 16,957 -37.17 0.0840
2020-05-15 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 311,828 -359,533 -53.55 26,989 -62.60 0.2198
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 671,361 273,598 68.78 72,165 101.34 0.2171
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 397,763 24,527 6.57 35,842 13.74 0.1206
2019-08-14 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 373,236 -356,564 -48.86 31,512 -50.99 0.1054
2019-05-15 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 729,800 -22,420 -2.98 64,295 19.69 0.2084
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 752,220 116,019 18.24 53,716 -31.33 0.2103
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 636,201 233,197 57.86 78,221 97.57 0.2132
2018-08-14 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 403,004 325,810 422.07 39,591 518.42 0.1180
2018-05-15 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 77,194 30,382 64.90 6,402 76.27 0.0213
2018-02-14 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 46,812 46,812 3,632 0.0118
2017-05-15 2017-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -83,923 -100.00 0 -100.00
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 83,923 83,923 3,248 0.0125
2016-05-16 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -10,823 -100.00 0 -100.00
2016-02-16 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 10,823 -64,636 -85.66 612 -79.62 0.0029
2015-11-16 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 75,459 -69,701 -48.02 3,003 -56.69 0.0154
2016-02-09 2015-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 145,160 86,262 146.46 6,933 196.41 0.0337
2015-08-14 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 145,160 6,933
2016-02-09 2015-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 58,898 58,898 0.00 2,339 0.0115
2015-05-15 2015-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 58,898 2,339
2016-02-09 2014-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 0 -18,057 -100.00 0 -100.00
2016-02-09 2014-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 18,057 -12,575 -41.05 283 -37.80 0.0013
2014-11-14 2014-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 18,057 283
2016-02-09 2014-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 30,632 30,632 -76.60 455 -62.77 0.0021
2014-08-14 2014-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 30,632 455
2014-05-15 2014-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -130,904 -100.00 0 -100.00
2014-02-14 2013-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 130,904 130,904 45.07 1,222 1.24 0.0068
2013-11-14 2013-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -90,238 -100.00 0 -100.00
2013-08-14 2013-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 90,238 90,238 1,207 0.0084
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-11-14 2016-09-30 13F NEUROCRINE BIOSCIENCES COM Call 4,200 213 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.